Alyssa Galaro, PhD
Preclinical Cell and Gene Therapy Reviewer FDA
Dr. Galaro joined the Office of Tissues and Advanced Therapies at FDA/CBER in 2018 as a Pharmacology and Toxicology Reviewer. Prior to joining CBER, she worked as a Study Director at a contract research organization and completed her PhD in biomedical engineering at the Johns Hopkins School of Medicine.